Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease

Journal of Nephrology

Volumn 28, Issue 1, 2015, Pages 73-80

  Russo, Domenico ^a   Bellasi, Antonio ^b   Pota, Andrea ^a   Russo, Luigi ^a   Di Iorio, Biagio ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SANT ANNA HOSPITAL   (Italy)

^c Department of Nephrology Ospedale Landolfi Solofra   (Italy)

Author keywords

Chronic kidney disease; Coronary calcification; Dialysis; Mortality; Phosphorus binder; Phosphorus restricted diet

Indexed keywords

CALCIUM CARBONATE; SEVELAMER; CHELATING AGENT; PHOSPHATE INTAKE; PHOSPHORUS;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY CALCIFICATION; DIALYSIS; DIET THERAPY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MINERAL METABOLISM; MORTALITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PHOSPHORUS RESTRICTION; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL; ADMINISTRATION AND DOSAGE; BLOOD; CAUSE OF DEATH; CLINICAL TRIAL; COMPLICATION; CORONARY BLOOD VESSEL; MIDDLE AGED; MULTICENTER STUDY; PHOSPHATE INTAKE; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; VASCULAR CALCIFICATION;

AGED; CALCIUM CARBONATE; CAUSE OF DEATH; CHELATING AGENTS; CORONARY VESSELS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PHOSPHORUS; PHOSPHORUS, DIETARY; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; SEVELAMER; VASCULAR CALCIFICATION;

EID: 84901836633     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-014-0071-2     Document Type: Article

References (26)

1. National Kidney Foundation (2003) K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42:S1–S201
2. Block GA, Preston S, Klassen PS et al (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208–2218
3. Young EW, Albert JM, Satayathum S, Goodkin DA et al (2005) Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study. Kidney Int 67:1179–1187
4. Lacson E, Wang W, Hakim RM, Teng M, Lazarus MJ (2008) Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access. Am J Kidney Dis 53:79–90
5. Isakova T, Gutierrez O, Chang Y et al (2009) Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol 20:388–396
6. KDIGO Clinical Practice Guideline for the Diagnosis (2009) Evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 76(S113):S1–S130
7. Bhuriya R, Li S, Chen S, McCullough PA, Bakris GL (2009) Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD Stages 3 and 4: an Analysis From the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 53(S4):S3–S10
8. Covic A, Kothawala P, Bernal M, Robbins S, Chalian A, Goldsmith D (2009) Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transpl 24:1506–1523
9. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curham G (2005) Relation between serum phosphorus level and cardiovascular event rate in people with coronary disease. Circulation 112:2627–2633
10. Kestenbaum B, Sampson JN, Rudser KD et al (2005) Serum phosphorus levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520–528
11. Zoccali C, Ruggenenti P, Perna A et al (2011) REIN Study Group: phosphorus may promote CKD progression and attenuate renoprotective effect of ACE inhibition. Am Soc Nephrol 22:1923–1930
12. Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska KA (2008) The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol 19:1092–1105
13. Kestenbaum B (2007) Phosphorus metabolism in the setting of chronic kidney disease: significance and recommendations for treatment. Semin Dial 20:286–294
14. Giachelli C (2009) The emerging role of phosphorus in vascular calcification. Kidney Int 75:890–897
15. Ix JH, De Boer IH, Peralta CA et al (2009) Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA. Clin J Am Soc Nephrol 4:609–615
16. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA (2009) Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20:397–404
17. Russo D, Corrao S, Miranda I et al (2007) Progression of coronary artery calcification in predialysis patients. Am J Nephrol 27:152–158
18. Russo D, Miranda I, Ruocco C et al (2007) The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 72:1255–1261
19. Russo D, Corrao S, Battaglia Y et al (2011) Progression of coronary artery calcification and cardiac events in patients with chronic renal disease not receiving dialysis. Kidney Int 80:112–118
20. Di Lullo L, Floccari F, Santoboni A et al (2013) Progression of cardiac valve calcification and decline of renal function in Non-dialysis CKD patients. J Nephrol 26:739–744
21. Di Iorio B, Bellasi A, Russo D (2012) Mortality in kidney disease patients treated with phosphorus binders: a randomized study. Clin J Am Soc Nephrol 7:487–493
22. Achenbach S, Ropers D, Pohle K et al (2002) Influence of lipid-lowering therapy on the progression of coronary artery calcification: a prospective evaluation. Circulation 106:1077–1082
23. Di Iorio B, Di Micco L, Torraca S et al (2012) Acute effects of very-low-protein diet on FGF23 Levels: a randomized study. Clin J Am Soc Nephrol 7:581–587
24. Block GA, Wheeler DC, Persky MS et al (2012) Effects of phosphorus binders in moderate CKD. J Am Soc Nephrol 23:1407–1415
25. Bellasi A, Cozzolino M, Adragao T, Di Iorio B, Russo D (2013) Phosphate binders in moderate chronic kidney disease: where do we stand? J Nephrol 26:993–1000. doi:10.5301/jn.5000258
26. Bellasi A, Mandreoli M, Baldrati L et al (2011) Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction. Clin J Am Soc Nephrol 6(4):883–891